Microbiome Times Partnering Forum: Meet Your Next Collaborator

Connect with decision-makers spanning the global microbial ecosystem to propel dealmaking and innovation

Bologna, 9-10 March 2027

Register Now for Free

In collaboration with

EMIH
MTIG

Meet Dealmakers from biotech, VCs, consumer care and pharma

Embarking from the impressive turnout in 2025, Microbiome Times Forum 2027 will see over 50 expert speakers and over 400 delegates descending on 9-10 March in Bologna for two full days of discussing, networking and uncovering the latest in microbial product innovation. Organised by Microbiome Times Magazine, the leading industry trade journal, the MT Partnering Forum will explore the industry's latest trends, scientific advancements, challenges, and opportunities to accelerate the development of novel microbial-based products.

Free-to-attend for start-ups, academic innovators, investors and healthcare companies, Microbiome Times Forum provides attendees with the opportunity to meet their next collaborator, partner or customer by scheduling over 30 one-to-one meetings through our tailor-made partnering platform.

Sponsors & Exhibitors

Biose Industrie
Lallemand Health Solutions
Maxwell Biosciences
Cmbio
Atlantia Clinical Trials
Byome Labs
BioLyo Technologies
Nimagen
Zymo Research
Quadram Institute
1928 Diagnostics
Lallemand Bio-Ingredients
Biofortis
BioMe
John Wiley & Sons
Revobiom
TNO
UK Gut-Immune-Brain Axis Network+
LABMaiTE
Unseen Bio
Sacco System
Prebiomics
Techtum Lab
Adiso Therapeutics
InnoGI Technologies
University of Liverpool
List Labs
Invitek Diagnostics
Nagi Bioscience
Capsugel | Lonza

Become an Event Sponsor

MT Forum 2027 Advisory Board

Oana Bernard
Chief Scientific Officer
Denise Kelly
Investment Advisor
Johan van Hylckama Vlieg
Co-founder & CSO
Guus Roeselers
Microbiome Lead - Unilever Foods
Matt Henn
Executive VP, CSO
Vanessa Ridaura
Senior Program Officer - Microbiome Products
Denis Guyonnet
Global Microbiome R&D Lead
Sou Miyake
Head of Venture Investment
Jonathan Lane
Associate Director of R&I
Herve Affagard
Founder & CEO

In collaboration with…

The goal of the EMIH is to promote medical innovation, based on the microbiota, as one of the public health priorities within the European Union. Its members are committed to developing advances in therapeutic, diagnostics and medical bioproduction based on the microbiota, in the field of human health, through a framework meeting the highest quality standards and also allowing economic balance, in order to maintain therapeutic innovation.

Through a collective voice, the MTIG membership works together to enhance the regulatory, investment, and commercial environment to accelerate microbiome therapeutic product development and expand availability of life-changing and life-saving FDA approved microbiome therapies to patients.

“MTIG looks forward to supporting Microbiome Times Partnering Forum this year as well! Our members are committed to fostering dialogue with stakeholders in the microbiome space to accelerate collaboration and innovation, and believe this event will serve as a venue to do just that.” Nik Kimes, Chairman at MTIG and CEO at Siolta Therapeutics
“The microbiome-based therapies sector has specific challenges like for any emerging field. Recent progress towards late-stage clinical trials is encouraging and we see signs of increased maturity. In this context, unity is strength. Microbiome Times' annual event is a unique opportunity to highlight key industry players and foster fruitful collaborations that can advance this critical field.” HervĂ© Affagard, President of EMIH and CEO of Maat Pharma

Start-up & Innovator Pitches

Get the scoop on the latest innovative products and services from start-up biotechs, academic innovators and research partners.

Partnering

Use our tailor-made dedicated one-to-one partnering platform to schedule private meetings throughout the event.

Networking

With multiple on and off site dedicated networking time and events, such as dinners, lunches, evening receptions, take advantage of multiple opportunities to connect with industry peers in a casual setting.

Industry Insights

The program is designed to address the latest trends, challenges and opportunities in microbiome. Hear from industry & science leaders to identify your next business move.